Detalhe da pesquisa
1.
Results of the first international quality control programme for oral targeted oncolytics.
Br J Clin Pharmacol
; 90(1): 336-343, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37776845
2.
Referral patterns of GIST patients: data from a nationwide study.
Acta Oncol
; 63: 28-34, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38353407
3.
Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study.
Support Care Cancer
; 32(5): 279, 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38594390
4.
The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer.
BJU Int
; 131(2): 244-252, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35861125
5.
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patients.
Acta Oncol
; 62(12): 1616-1624, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37856077
6.
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview.
Lancet Oncol
; 23(9): e406-e415, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36055309
7.
Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
Int J Cancer
; 150(2): 308-316, 2022 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34494665
8.
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer.
BMC Cancer
; 22(1): 228, 2022 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35236333
9.
'I thought I had fibroids, and now I don't': a mixed method study on health-related quality of life in uterine sarcoma patients.
Health Qual Life Outcomes
; 20(1): 65, 2022 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35443673
10.
Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data.
Support Care Cancer
; 30(6): 5137-5146, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35233640
11.
Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review.
BMC Health Serv Res
; 22(1): 829, 2022 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35761282
12.
Preparing tomorrow's medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs.
BMC Med Educ
; 22(1): 502, 2022 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35761247
13.
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
Int J Cancer
; 148(11): 2799-2806, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33428771
14.
The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumour.
Br J Clin Pharmacol
; 87(2): 326-335, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32358810
15.
Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study.
Cancer
; 126(24): 5283-5292, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33002193
16.
Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.
Br J Clin Pharmacol
; 86(2): 258-273, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31782166
17.
Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.
Acta Oncol
; 59(8): 975-982, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32476528
18.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Lancet Oncol
; 20(4): e200-e207, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30942181
19.
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
Oncologist
; 24(1): 110-116, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30082492
20.
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness study.
Br J Clin Pharmacol
; 85(9): 1994-2001, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31112617